Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001792044-25-000018
Filing Date
2025-05-08
Accepted
2025-05-08 09:21:14
Documents
104
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtrs-20250331.htm   iXBRL 10-Q 1938431
2 EX-10.1 ex_101xvtrsx20250331.htm EX-10.1 15044
3 EX-31.1 ex_311xvtrsx20250331.htm EX-31.1 8579
4 EX-31.2 ex_312xvtrsx20250331.htm EX-31.2 8640
5 EX-32 ex_32xvtrsx20250331.htm EX-32 6329
  Complete submission text file 0001792044-25-000018.txt   12066240

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtrs-20250331.xsd EX-101.SCH 74182
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtrs-20250331_cal.xml EX-101.CAL 105009
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtrs-20250331_def.xml EX-101.DEF 432124
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtrs-20250331_lab.xml EX-101.LAB 897131
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtrs-20250331_pre.xml EX-101.PRE 686271
107 EXTRACTED XBRL INSTANCE DOCUMENT vtrs-20250331_htm.xml XML 2181677
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39695 | Film No.: 25924183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)